Evaluation of hepatic findings by magnetic resonance after use of gadoxetic acid
Open Access
- 25 March 2021
- journal article
- research article
- Published by Wiley in Precision Radiation Oncology
- Vol. 5 (1), 18-24
- https://doi.org/10.1002/pro6.1112
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlasInsights into Imaging, 2012
- Primovist, Eovist: What to expect?Journal of Hepatology, 2012
- Dynamic contrast‐enhanced magnetic resonance imaging of abdominal solid organ and major vessel: Comparison of enhancement effect between Gd‐EOB‐DTPA and Gd‐DTPAJournal of Magnetic Resonance Imaging, 2009
- Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesionsEuropean Radiology, 2008
- Complicações do uso intravenoso de agentes de contraste à base de gadolínio para ressonância magnéticaRadiologia Brasileira, 2008
- Diagnostic Performance and Description of Morphological Features of Focal Nodular Hyperplasia in Gd-EOB-DTPA-Enhanced Liver Magnetic Resonance Imaging: Results of a Multicenter TrialInvestigative Radiology, 2008
- Currently used non-specific extracellular MR contrast mediaEuropean Radiology, 2003
- Benign versus Malignant Hepatic Nodules: MR Imaging Findings with Pathologic CorrelationRadioGraphics, 2002
- Hepatic Adenomas: Imaging and Pathologic FindingsRadioGraphics, 2001
- Contrast Agents for MR Imaging of the LiverRadiology, 2001